The Icahn School of Medicine at Mount Sinai has signed a memorandum of understanding with the Chiba Institute of Technology to use artificial intelligence to enhance clinical trials for cardiovascular disease, advance patient care…
Continue Reading
Background: People with coronary heart disease are at an increased risk of morbidity and mortality even if they attend cardiac rehabilitation. High sedentary behavior levels potentially contribute to this morbidity. Smartphone apps may be…
Continue Reading
Directing Women To the Right Menopause-Specific Care for ThemAnn Garnier, founder and CEO of Midday, an app launched in 2022 that incorporates Mayo Clinic’s virtual care, artificial intelligence and wearables, puts it this way:…
Continue Reading
Lucienne Marie Ide, M.D., PH.D., is the Founder & CEO of Rimidi While the pandemic has slowed, there appears to be no end in sight to the diabetes epidemic. The number of individuals diagnosed…
Continue Reading
By Shania Kennedy
August 30, 2023 – Researchers at Yale School of Medicine have developed a deep learning (DL) approach that can accurately detect aortic stenosis by analyzing heart ultrasound scans, according to a study published…
Continue Reading
Viz.ai gains FDA De Novo approval for its AI-driven algorithm detecting hypertrophic cardiomyopathy (HCM). This breakthrough software evaluates electrocardiograms, alerting specialists to suspicious findings for further assessment. The FDA’s recognition establishes a new category…
Continue Reading
The U.S. Food and Drug Administration’s approval of Viz.ai’s hypertrophic cardiomyopathy establishes a new category for cardiovascular machine learning-based notification software.WHY IT MATTERS
Viz.ai, a disease detection and intelligent care coordination company, said in its…
In 2022, President Biden re-ignited the Cancer Moonshot with a call to cut the cancer death rate by half and “improve the experience of people and families living with and surviving cancer.” Both goals are ambitious…
Continue Reading
What You Should Know: Today, Santa Cruz-based Capstan Medical, a developer of minimally invasive technology to address heart valve disease, announced $31.4M Series B investment round led by Eclipse.The Series B round included participation…
Continue Reading
About one in every four male deaths is related to heart disease, making it the leading cause of death for men in the U.S. One company is looking to alleviate the situation.
San Francisco-based Hims…
